Abstract

Sickle cell disease (SCD) is a hematological disorder leading to blood vessel occlusion accompanied by painful episodes and even death. Red blood cells (RBCs) of SCD patients have diverse shapes that reveal important biomechanical and bio-rheological characteristics, e.g. their density, fragility, adhesive properties, etc. Hence, having an objective and effective way of RBC shape quantification and classification will lead to better insights and eventual better prognosis of the disease. To this end, we have developed an automated, high-throughput, ex-vivo RBC shape classification framework that consists of three stages. First, we present an automatic hierarchical RBC extraction method to detect the RBC region (ROI) from the background, and then separate touching RBCs in the ROI images by applying an improved random walk method based on automatic seed generation. Second, we apply a mask-based RBC patch-size normalization method to normalize the variant size of segmented single RBC patches into uniform size. Third, we employ deep convolutional neural networks (CNNs) to realize RBC classification; the alternating convolution and pooling operations can deal with non-linear and complex patterns. Furthermore, we investigate the specific shape factor quantification for the classified RBC image data in order to develop a general multiscale shape analysis. We perform several experiments on raw microscopy image datasets from 8 SCD patients (over 7,000 single RBC images) through a 5-fold cross validation method both for oxygenated and deoxygenated RBCs. We demonstrate that the proposed framework can successfully classify sickle shape RBCs in an automated manner with high accuracy, and we also provide the corresponding shape factor analysis, which can be used synergistically with the CNN analysis for more robust predictions. Moreover, the trained deep CNN exhibits good performance even for a deoxygenated dataset and distinguishes the subtle differences in texture alteration inside the oxygenated and deoxygenated RBCs.

Highlights

  • Sickle cell disease (SCD), known as sickle cell anemia, is a type of inherited Red blood cells (RBCs) disorder associated with abnormal hemoglobin S (HbS) [1]

  • In SCD, in particular, there are multiple shape types in addition to the sickle shape, directly related to the sickle hemoglobin polymerization inside the RBC, which is induced by hypoxic conditions, e.g., in the post-capillary regions, in the spleen, etc

  • We develop a new computational framework based on deep convolutional networks in order to classify efficiently the heterogeneous shapes encountered in the sickle blood, and we complement our method with an independent shape factor analysis

Read more

Summary

Introduction

Sickle cell disease (SCD), known as sickle cell anemia, is a type of inherited RBC disorder associated with abnormal hemoglobin S (HbS) [1]. Available methods for treating SCD are mainly supportive and mostly aim at symptom control, but lack the active monitoring of the health status as well as the prediction of disease development in different clinical stages [4]. Recent developments in advanced medical imaging technology and computerized image processing methods could provide an effective tool in monitoring the status of SCD patients. Van beers et al [6] have shown highly specific and sensitive sickle and normal erythrocyte classification based on sickle imaging flow cytometry assay, a methodology that could be useful in assessing drug efficacy in SCD

Objectives
Methods
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.